Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial.
Graeser M, Feuerhake F, Gluz O, Volk V, Hauptmann M, Jozwiak K, Christgen M, Kuemmel S, Grischke EM, Forstbauer H, Braun M, Warm M, Hackmann J, Uleer C, Aktas B, Schumacher C, Kolberg-Liedtke C, Kates R, Wuerstlein R, Nitz U, Kreipe HH, Harbeck N.
Graeser M, et al. Among authors: feuerhake f.
J Immunother Cancer. 2021 May;9(5):e002198. doi: 10.1136/jitc-2020-002198.
J Immunother Cancer. 2021.
PMID: 33963012
Free PMC article.
Clinical Trial.